Literature DB >> 18497742

pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation.

Ian J Frew1, Claudio R Thoma, Strahil Georgiev, Andrea Minola, Manuela Hitz, Matteo Montani, Holger Moch, Wilhelm Krek.   

Abstract

In patients with von Hippel-Lindau (VHL) disease, renal cysts and clear cell renal cell carcinoma (ccRCC) arise from renal tubular epithelial cells containing biallelic inactivation of the VHL tumour suppressor gene. However, it is presumed that formation of renal cysts and their conversion to ccRCC involve additional genetic changes at other loci. Here, we show that cystic lesions in the kidneys of patients with VHL disease also demonstrate activation of the phosphatidylinositol-3-kinase (PI3K) pathway. Strikingly, combined conditional inactivation of Vhlh and the Pten tumour suppressor gene, which normally antagonises PI3K signalling, in the mouse kidney, elicits cyst formation after short latency, whereas inactivation of either tumour suppressor gene alone failed to produce such a phenotype. Interestingly, cells lining these cysts frequently lack a primary cilium, a microtubule-based cellular antenna important for suppression of uncontrolled kidney epithelial cell proliferation and cyst formation. Our results support a model in which the PTEN tumour suppressor protein cooperates with pVHL to suppress cyst development in the kidney.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497742      PMCID: PMC2435131          DOI: 10.1038/emboj.2008.96

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

2.  Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.

Authors:  Fangming Lin; Thomas Hiesberger; Kimberly Cordes; Angus M Sinclair; Lawrence S B Goldstein; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

3.  Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.

Authors:  Marija Velickovic; Brett Delahunt; Bryan McIver; Stefan K G Grebe
Journal:  Mod Pathol       Date:  2002-05       Impact factor: 7.842

4.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Authors:  Stefano J Mandriota; Kevin J Turner; David R Davies; Paul G Murray; Neil V Morgan; Heidi M Sowter; Charles C Wykoff; Eamonn R Maher; Adrian L Harris; Peter J Ratcliffe; Patrick H Maxwell
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

Review 6.  Multitasking by pVHL in tumour suppression.

Authors:  Ian J Frew; Wilhelm Krek
Journal:  Curr Opin Cell Biol       Date:  2007-11-19       Impact factor: 8.382

7.  Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma.

Authors:  Akio Horiguchi; Mototsugu Oya; Atsushi Uchida; Ken Marumo; Masaru Murai
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

8.  Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.

Authors:  Alexander Hergovich; Joanna Lisztwan; Robert Barry; Pia Ballschmieter; Wilhelm Krek
Journal:  Nat Cell Biol       Date:  2003-01       Impact factor: 28.824

Review 9.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

10.  Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract.

Authors:  Xinli Shao; Stefan Somlo; Peter Igarashi
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

View more
  75 in total

Review 1.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 3.  Cilium assembly and disassembly.

Authors:  Irma Sánchez; Brian David Dynlacht
Journal:  Nat Cell Biol       Date:  2016-06-28       Impact factor: 28.824

4.  Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.

Authors:  Herui Wang; Matthew J Shepard; Chao Zhang; Lijin Dong; Dyvon Walker; Liliana Guedez; Stanley Park; Yujuan Wang; Shida Chen; Ying Pang; Qi Zhang; Chun Gao; Wai T Wong; Henry Wiley; Karel Pacak; Emily Y Chew; Zhengping Zhuang; Chi-Chao Chan
Journal:  Cancer Res       Date:  2018-01-04       Impact factor: 12.701

5.  Leptin Elongates Hypothalamic Neuronal Cilia via Transcriptional Regulation and Actin Destabilization.

Authors:  Gil Myoung Kang; Yu Mi Han; Hyuk Whan Ko; Joon Kim; Byung Chul Oh; Ijoo Kwon; Min-Seon Kim
Journal:  J Biol Chem       Date:  2015-06-03       Impact factor: 5.157

Review 6.  The perennial organelle: assembly and disassembly of the primary cilium.

Authors:  E Scott Seeley; Maxence V Nachury
Journal:  J Cell Sci       Date:  2010-02-15       Impact factor: 5.285

Review 7.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

Review 8.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

9.  PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells.

Authors:  Jens Zehetner; Carsten Danzer; Stephan Collins; Katrin Eckhardt; Philipp A Gerber; Pia Ballschmieter; Juris Galvanovskis; Kenju Shimomura; Frances M Ashcroft; Bernard Thorens; Patrik Rorsman; Wilhelm Krek
Journal:  Genes Dev       Date:  2008-11-15       Impact factor: 11.361

Review 10.  Regulating the transition from centriole to basal body.

Authors:  Tetsuo Kobayashi; Brian D Dynlacht
Journal:  J Cell Biol       Date:  2011-05-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.